Glaukos

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.

CEO

Thomas William Burns

CEOThomas William Burns

Employees

995

Employees995

Headquarters

Aliso Viejo, California

HeadquartersAliso Viejo, California

Founded

1998

Founded1998

Employees

995

Employees995

GKOS Key Statistics

Market cap

5.54B

Market cap5.54B

Price-Earnings ratio

-42.25

Price-Earnings ratio-42.25

Dividend yield

—

Dividend yield—

Average volume

894.49K

Average volume894.49K

High today

$97.37

High today$97.37

Low today

$96.01

Low today$96.01

Open price

$96.01

Open price$96.01

Volume

32.38K

Volume32.38K

52 Week high

$163.71

52 Week high$163.71

52 Week low

$77.10

52 Week low$77.10

Analyst ratings

81%

of 16 ratings

Buy

81.3%

Hold

12.5%

Sell

6.3%

People also own

Based on the portfolios of people who own GKOS. This list is generated using Robinhood data, and it’s not a recommendation.

Marvell Technology

Taiwan Semiconductor Manu…